Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Atripla was produced by Gilead Sciences.

BMS/ Gilead's Atripla for HIV approved in EU

Atripla is formally approved for marketing in the 27 member states of the EU, as well as Norway and Iceland. ... three components contained in Atripla prior to initiation of their first antiretroviral treatment regimen.

China streamlines import of HIV drugs

time. Gliead filed the required application in August 2007. Gilead markets TDF in the US under the brand name Viread (tenofovir) and as a part of its Atripla (efavirenz/ tenofovir/ emtricitabine) ... Global sales for Bristol-Myers Squibb (BMS) and

Gilead study confirms Atripla efficacy

US-headquartered Gilead Sciences has reported positive from an ongoing trial evaluating the HIV treatment Atripla (efavirenz, emtricitabine, tenofovir) in comparison to a Combivir (AZT 3TC), with Sustiva (efavirenz) regimen. ... Truvada and Sustiva are

FDA approves maraviroc for treatment-experienced HIV patients

Gilead and Bristol-Myers Squibb's (BMS) Atripla (efavirenz/ tenofovir/ emtricitabine) has already been launched in the US and should reach the EU market in 2007. ... Atripla, which is experiencing rapid uptake, could bring in sales for Gilead and BMS of

[ Previous 5 results ] 2 3 4 5 6

COVID-19 Updates and Daily News

Featured jobs


Add my company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...
clinical research org
The important role of CROs in shaping the future of clinical research across Europe
Looking at the impact of COVID-19 on clinical research activities...